Printed from https://fiscalreceipts.com/program/0602787A/ — data as of August 12, 2026. Every figure is citation-backed; see the page online for per-number provenance.
Medical Technology
Watch this program: RSS · Atom
Budget Figures
FY2026 award data is a partial year — USASpending awards are reported on a rolling basis and the fiscal year does not close until September 30. why partial FY2026 data? →
| Fiscal year | Amount |
|---|---|
| FY24 | $139.5M |
| FY25 | $68.5M |
| FY26 | $143.3M |
All series figures: R-1 TOA · PB2026
The vertical scale does not start at zero: the baseline sits just below this program’s smallest year, so a low point on this line is not a small amount. Read the shape for direction and the grid below for the figures.
● actuals (line) · ○ enacted · ◇ request — gaps are editions the program is absent from, never interpolated.
| Series | FY15 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actuals | $74.3M | $74.2M | $78.3M | $88.9M | $87.2M | $110.9M | $101.3M | $124.0M | $79.9M | $139.5M | ||
| Enacted | $76.9M | $77.1M | $83.4M | $92.0M | $113.0M | $101.3M | $120.7M | $80.7M | $66.3M | $68.5M | ||
| Request | $77.1M | $83.4M | $90.1M | $99.2M | $95.5M | $91.7M | $34.0M | $66.3M | $68.5M | $143.3M |
blank = series not published for this year; – = absent from that edition.
Asked vs spent: the PB2024 book requested $66.3M for FY2024; the PB2026 book reported $139.5M as actual total obligation authority — $73.2M above the request. 139.5 − 66.3 = 73.2 USD millions — the compact figures above are rounded for reading.
Program Lineage
No predecessor/successor lineage was recorded for this program element — no FY-to-FY transfer into or out of this line was stated in the ingested J-books, and none was inferred from the program structure.
Description
Mission — Medical Technology
This Program Element (PE) supports application of knowledge gained through basic research to optimize drugs, medical devices, medical practices/procedures, and other preventive measures to include injury predictive strategies and tools essential to the protection and sustainment of Warfighter health and performance. Projects are coordinated with the Defense Health Agency. The cited research is consistent with the Under Secretary of Defense for Research and Engineering science and technology focus areas and the Army Modernization Strategy. All medical applied research is conducted in compliance with Food and Drug Administration (FDA) or Environmental Protection Agency (EPA) regulations. The FDA requires thorough testing in animals (preclinical testing) to ensure safety and, where possible, effectiveness prior to evaluation in controlled human clinical trials (upon transition to Advanced Technology Development). This PE focuses on research and refinement of technologies such as product formulation and purification and laboratory test refinement with the aim of identifying candidate solutions. This work often involves testing in animal models. The EPA also requires thorough testing of products, such as sterilants, disinfectants, repellents, and insecticides to ensure the environment is adequately protected before these products are licensed for use. Program refinement and execution is externally peer-reviewed and fully coordinated with all Services as well as other agencies through the Joint Technology Coordinating Groups of the Biomedical Community of Interest. The Biomedical Community of Interest, formed under the authority of the Assistant Secretary of Defense for Research and Engineering, serves to facilitate coordination and prevent unnecessary duplication of effort within the Department of Defenses (DoD) biomedical research community, as well as their associated enabling research areas. The FY 2026 request was reduced by $2.082 million for Advisory and Assistance Services to promote efficiencies and advance the policies of the Administration in alignment with Executive Order 14222, "Implementing the President's Department of Government Efficiency Cost Efficiency Initiative." The FY 2026 request was reduced by $0.116 million for civilian personnel to optimize the workforce in compliance with Executive Order 14210, "Implementing the President's Department of Government Efficiency Workforce Optimization Initiative."
Mission — Medical Technology (CA)
Congressional Interest Item funding provided for Medical Technology. The cited work is consistent with the Under Secretary of Defense for Research and Engineering priority focus areas and the Army Modernization Strategy.
Mission — Warfigher Health Applied Rsch Technology
This Project conducts research to prevent and protect Warfighters from training and operational injuries; refine mechanisms for detection of physiological (human physical and biochemical function) and psychological (mental) health problems; reduce the effects of trauma and promote rapid recovery from acute stress in far forward operational environments; evaluate hazards to head, neck, spine, eyes, and ears; set the standards for rapid return to duty; and determine new methods to sustain and enhance performance and readiness across the operational spectrum. This research provides medical information important to the design and operational use of military systems, and this work forms the basis for behavioral, training, and nutritional interventions. The four main areas of study are: (1) Physiological Health and Performance (2) Environmental Health and Protection (3) Injury Prevention and Reduction (4) Psychological Health and Resilience Research in this Project is coordinated with and complimentary to work done in Program Element (PE) 0602143A (Soldier Lethality Technology) and PE 0603118A (Soldier Lethality Advanced Technology). The cited research is consistent with the Under Secretary of Defense for Research and Engineering priority focus areas and the Army modernization strategy. Work in this Project is performed by the United States Army Medical Research and Development Command (USAMRDC) and Army Research Laboratory (ARL).
Mission — Cbt Casualty Care Applied Rsch Technology
This Project refines and assesses concepts, techniques, and materiel that improve survivability and treatment outcomes for Warfighters wounded during combat operations and treated under austere field conditions, including prolonged field care, and during medical evacuation, and maintains laboratory capability to perform these functions. Combat casualty care research addresses control of severe bleeding; resuscitation and stabilization; advanced automated life support systems suitable for use in forward areas, treatment of severe orthopedic injuries, treatment of severe burns, and combat-related brain injury. Promising efforts identified in this Project are further matured under Program Element (PE) 0603002A (Medical Advanced Technology). The cited research is consistent with the Under Secretary of Defense (Research and Engineering) science and technology focus areas and the Army Modernization Strategy. Research in this Project is performed by the United States Army Medical Research and Development Command (USAMRDC), Fort Detrick, MD.
Mission — Medical Technologies to Support Dispersed Ops Tech
This Project supports applied research in two task areas: 1) Medical Robotic and Autonomous Systems (Med-RAS) - will a) leverage emerging technologies in biomedical engineering, robotics, autonomy, unmanned systems, and assured position navigation and timing, to improve capabilities and expand capacity to deliver prolonged care, perform evacuation, delivery emergency resupply of medical material supplies (Class VIII), such as blood products, by ground or air, in dispersed and Multi-Domain Operations and b) establish medical performance criteria to ensure Soldiers are able to effectively perform manned-unmanned teaming tasks; and, 2) Virtual Health - will leverage emerging technologies in information science, artificial intelligence, telecommunications network engineering, and cyber security to enable prolonged care, remote telemonitoring, automated decision support, and telementoring between providers in Role of Care 3 and 4 to patients in Role of Care 1 and 2. Promising work in this Project will be further matured in PE 0603002A (Medical Advanced Technology) / Project MM7 (Enabling Med Cap to Support Dispersed OPS Adv Tech). The cited work is consistent with the Under Secretary of Defense for Research and Engineering priority focus areas and the Army Modernization Strategy. Work in this Project is performed by the United States Army Medical Research and Development Command (USAMRDC), Fort Detrick, MD.
Mission — Medical Technology
This Program Element (PE) supports application of knowledge gained through basic research to optimize drugs, medical devices, medical practices/procedures, and other preventive measures to include injury predictive strategies and tools essential to the protection and sustainment of Warfighter health and performance. Projects are coordinated with the Defense Health Agency. The cited research is consistent with the Under Secretary of Defense for Research and Engineering science and technology focus areas and the Army Modernization Strategy. All medical applied research is conducted in compliance with Food and Drug Administration (FDA) or Environmental Protection Agency (EPA) regulations. The FDA requires thorough testing in animals (preclinical testing) to ensure safety and, where possible, effectiveness prior to evaluation in controlled human clinical trials (upon transition to Advanced Technology Development). This PE focuses on research and refinement of technologies such as product formulation and purification and laboratory test refinement with the aim of identifying candidate solutions. This work often involves testing in animal models. The EPA also requires thorough testing of products, such as sterilants, disinfectants, repellents, and insecticides to ensure the environment is adequately protected before these products are licensed for use. Program refinement and execution is externally peer-reviewed and fully coordinated with all Services as well as other agencies through the Joint Technology Coordinating Groups of the Biomedical Community of Interest. The Biomedical Community of Interest, formed under the authority of the Assistant Secretary of Defense for Research and Engineering, serves to facilitate coordination and prevent unnecessary duplication of effort within the Department of Defenses (DoD) biomedical research community, as well as their associated enabling research areas. The FY 2026 request was reduced by $2.082 million for Advisory and Assistance Services to promote efficiencies and advance the policies of the Administration in alignment with Executive Order 14222, "Implementing the President's Department of Government Efficiency Cost Efficiency Initiative." The FY 2026 request was reduced by $0.116 million for civilian personnel to optimize the workforce in compliance with Executive Order 14210, "Implementing the President's Department of Government Efficiency Workforce Optimization Initiative."
Mission — Medical Technology (CA)
Congressional Interest Item funding provided for Medical Technology. The cited work is consistent with the Under Secretary of Defense for Research and Engineering priority focus areas and the Army Modernization Strategy.
Mission — Warfigher Health Applied Rsch Technology
This Project conducts research to prevent and protect Warfighters from training and operational injuries; refine mechanisms for detection of physiological (human physical and biochemical function) and psychological (mental) health problems; reduce the effects of trauma and promote rapid recovery from acute stress in far forward operational environments; evaluate hazards to head, neck, spine, eyes, and ears; set the standards for rapid return to duty; and determine new methods to sustain and enhance performance and readiness across the operational spectrum. This research provides medical information important to the design and operational use of military systems, and this work forms the basis for behavioral, training, and nutritional interventions. The four main areas of study are: (1) Physiological Health and Performance (2) Environmental Health and Protection (3) Injury Prevention and Reduction (4) Psychological Health and Resilience Research in this Project is coordinated with and complimentary to work done in Program Element (PE) 0602143A (Soldier Lethality Technology) and PE 0603118A (Soldier Lethality Advanced Technology). The cited research is consistent with the Under Secretary of Defense for Research and Engineering priority focus areas and the Army modernization strategy. Work in this Project is performed by the United States Army Medical Research and Development Command (USAMRDC) and Army Research Laboratory (ARL).
Mission — Cbt Casualty Care Applied Rsch Technology
This Project refines and assesses concepts, techniques, and materiel that improve survivability and treatment outcomes for Warfighters wounded during combat operations and treated under austere field conditions, including prolonged field care, and during medical evacuation, and maintains laboratory capability to perform these functions. Combat casualty care research addresses control of severe bleeding; resuscitation and stabilization; advanced automated life support systems suitable for use in forward areas, treatment of severe orthopedic injuries, treatment of severe burns, and combat-related brain injury. Promising efforts identified in this Project are further matured under Program Element (PE) 0603002A (Medical Advanced Technology). The cited research is consistent with the Under Secretary of Defense (Research and Engineering) science and technology focus areas and the Army Modernization Strategy. Research in this Project is performed by the United States Army Medical Research and Development Command (USAMRDC), Fort Detrick, MD.
Mission — Medical Technologies to Support Dispersed Ops Tech
This Project supports applied research in two task areas: 1) Medical Robotic and Autonomous Systems (Med-RAS) - will a) leverage emerging technologies in biomedical engineering, robotics, autonomy, unmanned systems, and assured position navigation and timing, to improve capabilities and expand capacity to deliver prolonged care, perform evacuation, delivery emergency resupply of medical material supplies (Class VIII), such as blood products, by ground or air, in dispersed and Multi-Domain Operations and b) establish medical performance criteria to ensure Soldiers are able to effectively perform manned-unmanned teaming tasks; and, 2) Virtual Health - will leverage emerging technologies in information science, artificial intelligence, telecommunications network engineering, and cyber security to enable prolonged care, remote telemonitoring, automated decision support, and telementoring between providers in Role of Care 3 and 4 to patients in Role of Care 1 and 2. Promising work in this Project will be further matured in PE 0603002A (Medical Advanced Technology) / Project MM7 (Enabling Med Cap to Support Dispersed OPS Adv Tech). The cited work is consistent with the Under Secretary of Defense for Research and Engineering priority focus areas and the Army Modernization Strategy. Work in this Project is performed by the United States Army Medical Research and Development Command (USAMRDC), Fort Detrick, MD.
Justification
Accomplishments & Planned Programs (22)
Operational Risk Planning Tools for Battlefield Environmental Threats
This effort investigates and incorporates mechanisms for health risks of heat, cold, and altitude injuries to develop guidelines and advise countermeasure development for operations in extreme environments. Investigates health risks from industrial chemicals and pollutants found in dense urban and subterranean (SubT) environments in which Soldiers operate.
Prevention of Soldier Performance Degradation in Extreme Environments
This effort develops and matures non-invasive technologies, decision-aid tools, and other countermeasure to prevent and enhance Soldier performance in extreme environments of heat, cold, altitude, dense urban and SubT environments. This effort includes validation of approved pharmaceuticals as well as provides improved sensors and predictive algorithms models.
Leader Decision Aid to Manage Blast Head Injury in All Settings
Develop injury risk assessment/guidance/criteria that will inform the development of technologies (i.e., personal protection equipment, vehicles) and strategies (i.e., health hazard assessments) to protect the Soldier against current and emerging operational threats (i.e., blast, blunt, ballistic, and accelerative).
Physical Fitness Standards to Prevent Musculoskeletal Injuries
Develops validated standards and strategies to optimize Soldier readiness and performance through mitigation of musculoskeletal injury (MSKI), facilitate quick return to combat effectiveness after MSKI, and decrease risk of re-injury once cleared to return to duty.
Leader Tools to Reduce Musculoskeletal Injury In All Settings
Enhances the Army's understanding of the physiological mechanisms underlying musculoskeletal injuries and identifies countermeasures to mitigate injury risk to reduce musculoskeletal injuries in new recruits, thereby directly improving readiness and lethality of the force.
Forward Neuro-Muscular Skeletal Injury Assessment
Focus on developing portable imaging technologies to identify soft tissue musculoskeletal injury severity in the field and generate capabilities to guide musculoskeletal injury management to inform appropriate evacuation vs. return to duty (RTD) decisions.
Biomedical Performance Enhancement
This effort evaluates strategies and technologies that enhance Soldier physical and mental performance in multi-Domain operations. Additional efforts concentrate on characterization of physiological and genetic factors that contribute to physiological resilience to military stressors.
Expeditionary Force Nutrition to Improve Performance
Characterizes and refines field fueling and garrison practices to sustain Medical readiness, military performance and recovery from military operations. Evaluates combat ration components to sustain Medical Readiness and performance in deployed, disaggregated and dispersed operations.
Energy Field Biological Effects and Mechanisms
Investigate the area of emerging directed energy threat mechanisms and biological effects. Conduct research to support the Department of Defense and US Government's threat mitigation strategy.
Future En Route Casualty Care Sustainment System Cap Set
This effort performs applied research to support development of technologies that will increase capability and capacity to provide combat casualty care from point of injury to final point of care.
Medical Robotic and Autonomous Systems
Research, design, and validate autonomous and unmanned capabilities to deliver high quality combat casualty care in dispersed operations with limited or absent medical care personnel, and future medical robotic systems capable of providing autonomous combat casualty care while optimizing the medical logistic footprint in far-forward and dispersed geographic environments in support of the Army Multi-Domain Operations (MDO) concept and the Army Force 2025 and Beyond vision documents.
Operational Risk Planning Tools for Battlefield Environmental Threats
This effort investigates and incorporates mechanisms for health risks of heat, cold, and altitude injuries to develop guidelines and advise countermeasure development for operations in extreme environments. Investigates health risks from industrial chemicals and pollutants found in dense urban and subterranean (SubT) environments in which Soldiers operate.
Prevention of Soldier Performance Degradation in Extreme Environments
This effort develops and matures non-invasive technologies, decision-aid tools, and other countermeasure to prevent and enhance Soldier performance in extreme environments of heat, cold, altitude, dense urban and SubT environments. This effort includes validation of approved pharmaceuticals as well as provides improved sensors and predictive algorithms models.
Leader Decision Aid to Manage Blast Head Injury in All Settings
Develop injury risk assessment/guidance/criteria that will inform the development of technologies (i.e., personal protection equipment, vehicles) and strategies (i.e., health hazard assessments) to protect the Soldier against current and emerging operational threats (i.e., blast, blunt, ballistic, and accelerative).
Physical Fitness Standards to Prevent Musculoskeletal Injuries
Develops validated standards and strategies to optimize Soldier readiness and performance through mitigation of musculoskeletal injury (MSKI), facilitate quick return to combat effectiveness after MSKI, and decrease risk of re-injury once cleared to return to duty.
Leader Tools to Reduce Musculoskeletal Injury In All Settings
Enhances the Army's understanding of the physiological mechanisms underlying musculoskeletal injuries and identifies countermeasures to mitigate injury risk to reduce musculoskeletal injuries in new recruits, thereby directly improving readiness and lethality of the force.
Forward Neuro-Muscular Skeletal Injury Assessment
Focus on developing portable imaging technologies to identify soft tissue musculoskeletal injury severity in the field and generate capabilities to guide musculoskeletal injury management to inform appropriate evacuation vs. return to duty (RTD) decisions.
Biomedical Performance Enhancement
This effort evaluates strategies and technologies that enhance Soldier physical and mental performance in multi-Domain operations. Additional efforts concentrate on characterization of physiological and genetic factors that contribute to physiological resilience to military stressors.
Expeditionary Force Nutrition to Improve Performance
Characterizes and refines field fueling and garrison practices to sustain Medical readiness, military performance and recovery from military operations. Evaluates combat ration components to sustain Medical Readiness and performance in deployed, disaggregated and dispersed operations.
Energy Field Biological Effects and Mechanisms
Investigate the area of emerging directed energy threat mechanisms and biological effects. Conduct research to support the Department of Defense and US Government's threat mitigation strategy.
Future En Route Casualty Care Sustainment System Cap Set
This effort performs applied research to support development of technologies that will increase capability and capacity to provide combat casualty care from point of injury to final point of care.
Medical Robotic and Autonomous Systems
Research, design, and validate autonomous and unmanned capabilities to deliver high quality combat casualty care in dispersed operations with limited or absent medical care personnel, and future medical robotic systems capable of providing autonomous combat casualty care while optimizing the medical logistic footprint in far-forward and dispersed geographic environments in support of the Army Multi-Domain Operations (MDO) concept and the Army Force 2025 and Beyond vision documents.
Budget Line Items(workbook-cited)
P-1/R-1 workbook Total Obligation Authority basis (USD thousands) · PB2026.
Exhibit R-1
| Account | Org | Type | Amount |
|---|---|---|---|
| Research, Development, Test and Evaluation, Army | A | FY24 Actuals | $139.5M |
| Research, Development, Test and Evaluation, Army | A | FY25 Enacted | $68.5M |
| Research, Development, Test and Evaluation, Army | A | FY25 Total | $68.5M |
| Research, Development, Test and Evaluation, Army | A | FY26 Disc. Request | $143.3M |
| Research, Development, Test and Evaluation, Army | A | FY26 Total | $143.3M |
Budget Details(R-2/P-40 facts)
J-book detail basis (R-2/P-40, USD millions) · PB2026 — a different accounting basis from the P-1/R-1 workbook TOA above; where the two disagree, the reconciliation strip under Budget Figures shows both.
Wider than this screen — swipe the table sideways for the remaining fiscal-year columns.
| Project | FY24 Actuals | FY25 Total | FY26 Base | FY26 Request |
|---|---|---|---|---|
| Program Element | $139.5M | $68.5M | $143.3M | $143.3M |
| MK4: Warfigher Health Applied Rsch Technology | $62.4M | $67.3M | $141.8M | $141.8M |
| MM4: Cbt Casualty Care Applied Rsch Technology | $1.77M | $1.11M | $1.54M | $1.54M |
| MM6: Medical Technologies to Support Dispersed Ops Tech | $120.0K | $119.0K | — | — |
| BS7: Medical Technology (CA) | $75.2M | — | — | — |
No follow-the-dollar view — this program's awards haven't been crosswalked at high confidence (flows cover 17 of 1,741 programs). why coverage is partial? →
Awards
No awards are linked to this program element at high confidence — the budget→award crosswalk only asserts links it can defend, and this line has none yet.
Lobbying Mentions
No Senate LDA lobbying filing in the tracked data mentions this program element by code or alias.
Oversight
Department-level designation (not specific to this program)
GAO lists 5 high-risk areas for DOD as a whole. That designation covers the department, not Medical Technology — no program-specific GAO finding for this line is in the ingested data. See the DOD oversight record.
No research dossier for this program — dossiers cover 50 of 1,741 programs, the largest fully J-book-detailed lines by FY2026 requested dollars. why no dossier here? →